...
首页> 外文期刊>Recent Patents on Inflammation & Allergy Drug Discovery >Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action
【24h】

Topical Use of Sucralfate in Epithelial Wound Healing: Clinical Evidence and Molecular Mechanisms of Action

机译:硫糖铝在上皮伤口愈合中的局部使用:临床证据和作用的分子机制

获取原文
获取原文并翻译 | 示例
           

摘要

Sucralfate is a basic aluminium salt of sucrose octasulphate which was orally employed for prevention and treatment of several gastrointestinal diseases including gastroesophageal reflux, gastric and duodenal ulcer. Recent studies have employed sucralfate as a topical drug for the healing of several types of epithelial wounds such as ulcers, inflammatory dermatitis, mucositis and burn wounds. Epithelial wound healing is a well orchestrated process involving hemostasis, inflammatory reaction, cell proliferation and tissue remodeling which leads to granulation tissue development and filling of the wound space. This report will review clinical evidence on the use of topical sucralfate for the management of epithelial lesions and deal with the current knowledge on the molecular mechanisms of action of this compound towards the epithelial wound healing process and will also discuss relevant patents.
机译:硫糖铝是蔗糖八硫酸盐的碱性铝盐,其口服用于预防和治疗多种胃肠道疾病,包括胃食管反流,胃和十二指肠溃疡。最近的研究已经使用硫糖铝作为局部药物来治愈几种类型的上皮伤口,例如溃疡,炎性皮炎,粘膜炎和烧伤伤口。上皮伤口愈合是一个精心策划的过程,涉及止血,炎症反应,细胞增殖和组织重塑,从而导致肉芽组织发育和伤口空间充盈。该报告将审查关于使用硫糖铝局部治疗上皮病变的临床证据,并探讨该化合物对上皮伤口愈合过程的分子机制的最新知识,还将讨论相关专利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号